BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38484895)

  • 1. ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
    Chen H; Xing C; Lei H; Yan B; Zhang H; Tong T; Guan Y; Kang Y; Pang J
    J Control Release; 2024 Apr; 368():637-649. PubMed ID: 38484895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Assessment of Enhanced Chemodynamic Therapy by an FeMnO
    Dirersa WB; Kan TC; Getachew G; Wibrianto A; Ochirbat S; Rasal A; Chang J; Chang JY
    ACS Appl Mater Interfaces; 2023 Dec; 15(48):55258-55275. PubMed ID: 38013418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy.
    Xing C; Chen H; Guan Y; Zhang S; Tong T; Ding N; Luo T; Kang Y; Pang J
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):864-876. PubMed ID: 36029600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.
    Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-active polyphenol nanoparticles deprive endogenous glutathione of electrons for ROS generation and tumor chemodynamic therapy.
    Wang Y; Wang J; Jiao Y; Chen K; Chen T; Wu X; Jiang X; Bu W; Liu C; Qu X
    Acta Biomater; 2023 Dec; 172():423-440. PubMed ID: 37778486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
    Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
    Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
    Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
    Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Huang S; Zhao N; Qian Z; Yuan W
    J Mater Chem B; 2023 Apr; 11(16):3727-3739. PubMed ID: 37067286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of DOX-dimer with bi-functionalized chitooligosaccharide for tumor-specific self-boosted drug release and synergistic chemo/chemodynamic therapy.
    Xie P; Liu P
    Carbohydr Polym; 2023 Nov; 320():121210. PubMed ID: 37659811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.
    Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y
    Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy.
    Shi J; Wang Y; Wu Y; Li J; Fu C; Li Y; Xie X; Fan X; Hu Y; Hu C; Zhang J
    ACS Appl Mater Interfaces; 2024 Feb; 16(6):7576-7592. PubMed ID: 38316581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-Active Ferrocene Quencher-Based Supramolecular Nanomedicine for NIR-II Fluorescence-Monitored Chemodynamic Therapy.
    Yu M; Ye Z; Liu S; Zhu Y; Niu X; Wang J; Ao R; Huang H; Cai H; Liu Y; Chen X; Lin L
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202318155. PubMed ID: 38109458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
    Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
    Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molybdenum-oxo-sulfide quantum dot-based nanocarrier: Efficient generation of reactive oxygen species via photo/chemodynamic therapy and stimulus-induced drug release.
    Dirersa WB; Getachew G; Wibrianto A; Rasal AS; Gurav VS; Zakki Fahmi M; Chang JY
    J Colloid Interface Sci; 2023 Oct; 647():528-545. PubMed ID: 37230831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.
    Chen D; Zhang G; Li R; Guan M; Wang X; Zou T; Zhang Y; Wang C; Shu C; Hong H; Wan LJ
    J Am Chem Soc; 2018 Jun; 140(24):7373-7376. PubMed ID: 29799737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.